NAFLD affects approximately 2030% of the UK population and is strongly associated with metabolic syndrome, type 2 diabetes, obesity, and insulin resistance
Geng J, Yu S, Zhao H, Sun X, Li X, Wang P, et al
J Pathol 217(4):571580 Shim WS, Ho IA, Wong PE (2007) Angiopoietin: a TIE(d) balance in tumor angiogenesis
By stimulating natural GH production, scientists have found that Sermorelin can contribute to the development and maintenance of healthy muscles, reduce body fat, and improve overall energy levels
Individuals who should avoid or exercise extreme caution include: Immunocompromised patients : Those with primary immunodeficiency disorders, HIV/AIDS with low CD4 counts, active chemotherapy recipients, or individuals taking immunosuppressive medications (corticosteroids, biologics, transplant drugs) face increased infection risk Critically ill or hospitalized patients : Severely ill individuals, particularly those in intensive care settings or with compromised gut barrier function, should not receive probiotics outside controlled clinical protocols Patients with central venous catheters : Indwelling lines provide potential routes for bacterial translocation into the bloodstream Premature infants : The FDA issued a safety warning in October 2023 against using probiotics in preterm infants due to risk of invasive infection Patients with severe acute pancreatitis : Clinical guidelines from the American College of Gastroenterology recommend against probiotic use in this condition due to potential harm [15] [16] Additional populations requiring medical consultation: Pregnant and breastfeeding women should consult healthcare providers before using GLP-1 probiotics, as safety data in these populations remains limited
Who Should and Should Not Use GLP-1 with Hypothyroidism: A Provider Decision Framework Most patients with well-controlled hypothyroidism (stable TSH in normal range) are candidates for GLP-1 therapy
